| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.2 |